{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:58:53Z","timestamp":1790135933473,"version":"4.0.1"},"reference-count":49,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K18947"],"award-info":[{"award-number":["15K18947"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K15533"],"award-info":[{"award-number":["17K15533"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04714"],"award-info":[{"award-number":["17H04714"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H04341"],"award-info":[{"award-number":["20H04341"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08356"],"award-info":[{"award-number":["17K08356"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI from the Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06702"],"award-info":[{"award-number":["21K06702"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Levetiracetam (LEV) suppresses the upregulation of proinflammatory molecules that occurs during epileptogenesis after status epilepticus (SE). Based on previous studies, LEV likely helps prevent the onset of epilepsy after insults to the brain, unlike other conventional anti-epileptic drugs. Recently, we discovered that the increase in Fosl1 expression that occurs after lipopolysaccharide (LPS) stimulation is suppressed by LEV and that Fosl1 inhibition suppresses inflammation in BV-2 microglial cells. These data indicate that Fosl1 is an important target of LEV and a key factor in preventing epilepsy onset. In this study, we examined the effects of LEV on Fosl1 expression and neuroinflammation in vivo. During epileptogenesis, the post-SE upregulation of hippocampal levels of Fosl1 and many inflammatory factors were suppressed by LEV. Fosl1 expression showed a characteristic pattern different from that of the expression of Fos, an immediate-early gene belonging to the same Fos family. At 2 days after SE, Fosl1 was predominantly expressed in astrocytes but was rarely detected in microglia, whereas Fos expression was distributed in various brain cell types. The expression of A2 astrocyte markers was similar to that of Fosl1 and was significantly suppressed by LEV. These results suggest that LEV may regulate astrocyte reactivity through regulation of Fosl1.<\/jats:p>","DOI":"10.3390\/ijms23147608","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:48:00Z","timestamp":1657493280000},"page":"7608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Regulation of Inflammation-Related Genes through Fosl1 Suppression in a Levetiracetam-Treated Pilocarpine-Induced Status Epilepticus Mouse Model"],"prefix":"10.3390","volume":"23","author":[{"given":"Rie","family":"Komori","sequence":"first","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taira","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7949-1003","authenticated-orcid":false,"given":"Aya","family":"Yokota-Nakatsuma","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuka","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Kubo","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Kozawa","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kono","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Program of Biomedical Science, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima 739-8521, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Laboratory for Pharmacotherapy and Experimental Neurology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima 769-2193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","article-title":"Adult epilepsy","volume":"367","author":"Duncan","year":"2006","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/epi.14458","article-title":"Epilepsy in Asia: Disease burden, management barriers, and challenges","volume":"60","author":"Trinka","year":"2019","journal-title":"Epilepsia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1528-1157.2001.28900.x","article-title":"Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials","volume":"42","author":"Temkin","year":"2001","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1528-1157.44.s10.6.x","article-title":"Risk factors for posttraumatic seizures in adults","volume":"44","author":"Temkin","year":"2003","journal-title":"Epilepsia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2008.02005.x","article-title":"Preventing and treating posttraumatic seizures: The human experience","volume":"50","author":"Temkin","year":"2009","journal-title":"Epilepsia"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: The mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.1120195109","article-title":"Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2","volume":"109","author":"Jiang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000001487","article-title":"Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"84","author":"Krumholz","year":"2015","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eplepsyres.2008.08.008","article-title":"Levetiracetam in newly diagnosed late-onset post-stroke seizures: A prospective observational study","volume":"82","author":"Belcastro","year":"2008","journal-title":"Epilepsy Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneurol.2012.445","article-title":"Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy","volume":"69","author":"Klein","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/epi.12326","article-title":"Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy","volume":"54","author":"Pearl","year":"2013","journal-title":"Epilepsia"},{"key":"ref_13","first-page":"489","article-title":"Levetiracetam: A review of its use in epilepsy","volume":"71","year":"2011","journal-title":"Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2015.03.005","article-title":"Prevention of status epilepticus-induced brain edema and neuronal cell loss by repeated treatment with high-dose levetiracetam","volume":"1608","author":"Itoh","year":"2015","journal-title":"Brain Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2016.09.038","article-title":"Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice","volume":"1652","author":"Itoh","year":"2016","journal-title":"Brain Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134363","DOI":"10.1016\/j.neulet.2019.134363","article-title":"Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine","volume":"708","author":"Itoh","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Niidome, K., Taniguchi, R., Yamazaki, T., Tsuji, M., Itoh, K., and Ishihara, Y. (2021). FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222010962"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1242\/jcs.01589","article-title":"AP-1 subunits: Quarrel and harmony among siblings","volume":"117","author":"Hess","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1172\/JCI70405","article-title":"JUNB\/AP-1 controls IFN-\u03b3 during inflammatory liver disease","volume":"123","author":"Thomsen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1038\/s41598-020-69735-z","article-title":"FOSL1 is a novel mediator of endotoxin\/lipopolysaccharide-induced pulmonary angiogenic signaling","volume":"10","author":"Nitkin","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1471-4892(02)00015-2","article-title":"GABAA receptor function and pharmacology in epilepsy and status epilepticus","volume":"3","author":"Macdonald","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0306-4522(93)90369-Q","article-title":"Correlations between immediate early gene induction and the persistence of long-term potentiation","volume":"56","author":"Abraham","year":"1993","journal-title":"Neuroscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.21-14-05089.2001","article-title":"Experience-dependent gene expression in the rat hippocampus after spatial learning: A comparison of the immediate-early genes Arc, c-fos, and zif268","volume":"21","author":"Guzowski","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fphar.2012.00132","article-title":"The role of astroglia in the epileptic brain","volume":"3","author":"Losi","year":"2012","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/glia.20394","article-title":"Functional changes in astroglial cells in epilepsy","volume":"54","author":"Binder","year":"2006","journal-title":"Glia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainresrev.2009.10.004","article-title":"Astrocyte dysfunction in epilepsy","volume":"63","author":"Seifert","year":"2010","journal-title":"Brain Res. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fncom.2012.00061","article-title":"Astroglial networks and implications for therapeutic neuromodulation of epilepsy","volume":"6","author":"Witcher","year":"2012","journal-title":"Front. Comput. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/epi.12473","article-title":"Glia and epilepsy: Experimental investigation of antiepileptic drugs in an astroglia\/microglia co-culture model of inflammation","volume":"55","author":"Dambach","year":"2014","journal-title":"Epilepsia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/glia.20167","article-title":"Ischemia-induced programmed cell death in astrocytes","volume":"50","author":"Giffard","year":"2005","journal-title":"Glia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fncel.2018.00401","article-title":"Astrocyte Heterogeneity in the Adult Central Nervous System","volume":"12","author":"Miller","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105080","DOI":"10.1016\/j.neuint.2021.105080","article-title":"A1\/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?","volume":"148","author":"Fan","year":"2021","journal-title":"Neurochem. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40263-015-0248-9","article-title":"Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review","volume":"29","author":"Weijenberg","year":"2015","journal-title":"CNS Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004647-199703000-00001","article-title":"DNA fragmentation and Prolonged expression of c-fos, c-jun, and hsp70 in kainic acid-induced neuronal cell death in transgenic mice overexpressing human CuZn-superoxide dismutase","volume":"17","author":"Kondo","year":"1997","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng859","article-title":"c-fos regulates neuronal excitability and survival","volume":"30","author":"Zhang","year":"2002","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","article-title":"Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer\u2019s disease","volume":"9","author":"Sobue","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.1038\/ncomms15132","article-title":"Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism","volume":"8","author":"Hasel","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/35097593","article-title":"Defining glial cells during CNS development","volume":"2","author":"Zhang","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s13311-018-0630-7","article-title":"Glial Cells Shape Pathology and Repair After Spinal Cord Injury","volume":"15","author":"Gaudet","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12974-019-1524-2","article-title":"An update on reactive astrocytes in chronic pain","volume":"16","author":"Li","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1080\/15384101.2019.1667189","article-title":"Blocking Notch signal pathway suppresses the activation of neurotoxic A1 astrocytes after spinal cord injury","volume":"18","author":"Qian","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.it.2007.01.005","article-title":"Astrocytes are active players in cerebral innate immunity","volume":"28","author":"Farina","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/mds.27718","article-title":"The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration","volume":"34","author":"Hinkle","year":"2019","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/REP-17-0243","article-title":"Regulation and action of early growth response 1 in bovine granulosa cells","volume":"54","author":"Han","year":"2017","journal-title":"Reproduction"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.12659\/MSM.914044","article-title":"Transcriptional regulation of early growth response gene-1 (EGR1) is associated with progression of nonalcoholic fatty liver disease (NAFLD) in patients with insulin resistance","volume":"25","author":"Li","year":"2019","journal-title":"Med. Sci. Monit."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:47:12Z","timestamp":1760140032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/14\/7608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":49,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["ijms23147608"],"URL":"https:\/\/doi.org\/10.3390\/ijms23147608","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,9]]}}}